Bausch + Lomb Reports 3 Percent Revenue Growth in 2025 First Quarter and Updates Full-Year Guidance After IOL Recall; Faces Tariff Challenges
Published on May 1, 2025
VAUGHAN, Ontario—Global eye health company Bausch + Lomb Corporation (NYSE/TSX: BLCO) has announced its first quarter 2025 financial results, demonstrating total reported revenue of $1.137 billion, as compared with $1.099 billion in the first quarter of 2024, an increase of $38 million, or 3 percent. Excluding the unfavorable impact of foreign exchange of $19 million, revenue increased by approximately 5 percent on a constant currency basis compared with the first quarter of 2024. Further, revenue increased in all three segments on a constant currency basis, including vision care, surgical and pharmaceutical, the company advised.